<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cure - Cure Member Spotlight</title>
    <link>https://wewillcure.com/insights/cure-member-spotlight</link>
    <description>Latest content from Cure in Cure Member Spotlight</description>
    <language>en</language>
    <lastBuildDate>Sun, 09 Aug 2026 07:48:20 GMT</lastBuildDate>
    <atom:link href="https://wewillcure.com/insights/cure-member-spotlight/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/cure-member-spotlight-steven-jenkins</guid>
      <title><![CDATA[This Digital Health Startup Uses Small Rewards to Change Hard-to-Treat Behavior]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/cure-member-spotlight-steven-jenkins</link>
      <description><![CDATA[Steve Jenkins built Q2i's first tool for one doctor treating addiction. The same idea, rewarding people fast for progress they can see, now runs through products for addiction, probation, and diabetes.]]></description>
      <pubDate>Fri, 07 Aug 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5I6QFvzGT68PnpwGJEqoaG/f22f732609fffc4ace8afdf99762e445/member_spotlight_hero_Steven_Jenkins_16x9.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/how-a-quantum-chemist-decoded-her-own-symptoms-and-built-a-womens-health</guid>
      <title><![CDATA[How a Quantum Chemist Decoded Her Own Symptoms and Built a Women’s Health Startup]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/how-a-quantum-chemist-decoded-her-own-symptoms-and-built-a-womens-health</link>
      <description><![CDATA[After 20 years of misdiagnosis, Tamar Zelovich-Hod used the pattern-finding methods from her quantum chemistry research to identify her own endometriosis, then built them into SymptoLab, a decision-support tool for physicians.]]></description>
      <pubDate>Wed, 29 Jul 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/iWp1hkamyV6MAv2k9WbB0/85b9c7bd39e4e999c3637aff2e50db54/260729_member_spotlight_hero_tamara_zelovich-hod_16x9.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/how-a-google-search-became-a-mission-to-eliminate-icu-infections</guid>
      <title><![CDATA[How a Google Search Became a Mission to Eliminate ICU Infections]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/how-a-google-search-became-a-mission-to-eliminate-icu-infections</link>
      <description><![CDATA[With no background in healthcare, Robert Gangi turned a Google search into a mission to stop ventilator-associated pneumonia (VAP), transforming an overlooked ICU problem into a venture-backed medical device company.]]></description>
      <pubDate>Tue, 23 Jun 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/abWkjXcDPxNuH21XJhTew/2433ce065737acdef4e5b2cb5e4b0fca/Cure_MSL_hero_article_Russell_Bar-100.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/cure-member-spotlight-russell-bar</guid>
      <title><![CDATA[Cure Member Spotlight: Russell Bar]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/cure-member-spotlight-russell-bar</link>
      <description><![CDATA[A Q&A with the co-founder and CEO of Hi-Rx, a platform that connects pharmaceutical sponsors and clinical sites with on-demand nurses, on why clinical trial recruitment keeps breaking at the same point, and what a nurse network can do that a CRO can't.]]></description>
      <pubDate>Tue, 09 Jun 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4hV1qNpV2YkFxVgoqWbHMO/e261a75a74a3b47c9e2a20a5670d481c/Cure_MSL_hero_article_Russell_Bar-100.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/cure-member-spotlight-chetan-mishra-rhizome-ai</guid>
      <title><![CDATA[Cure Member Spotlight: Chetan Mishra]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/cure-member-spotlight-chetan-mishra-rhizome-ai</link>
      <description><![CDATA[A Q&A with the founder of Rhizome AI, on why regulatory affairs teams are still searching PDFs by hand, and what it will take to give them something better.]]></description>
      <pubDate>Tue, 02 Jun 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/11sVqpz3CDqiIkPi2Pm1p0/773927be4957e85f45e87522facdb94a/Cure_MSL_hero_article_Chetan_Mishra-100.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/cure-member-spotlight-ryan-confer-genprex</guid>
      <title><![CDATA[Cure Member Spotlight: Ryan Confer]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/cure-member-spotlight-ryan-confer-genprex</link>
      <description><![CDATA[A Q&A with CEO of Genprex on the intravenous gene therapy platform behind Reqorsa, how the company is advancing pipelines in both lung cancer and diabetes, and what it still needs to prove.]]></description>
      <pubDate>Mon, 11 May 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1vBFARMBqFqaGlgNc7YXsu/1b05f39972f9ed6852715df5932d4fb5/thumbnail_mem_spotlight_ryan_confer_16x9.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/cure-member-spotlight-peter-farmakis-32-biosciences</guid>
      <title><![CDATA[Cure Member Spotlight: Peter Farmakis]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/cure-member-spotlight-peter-farmakis-32-biosciences</link>
      <description><![CDATA[A Q&A with Peter Farmakis, CEO of 32 Biosciences, on building a company around the biology most microbiome startups missed, and what it takes to move from academic science to a fundable, clinical-stage therapeutic.]]></description>
      <pubDate>Fri, 24 Apr 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2o6lNfd39iW4zm93PPbGRZ/ee94e96bb59daafedc23613e63067157/thumbnail_mem_spotlight_peter_farmakis_16x9.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/cure-member-spotlight-larry-raoul-james-mindlab</guid>
      <title><![CDATA[Cure Member Spotlight: Larry Raoul James]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/company-profiles/cure-member-spotlight-larry-raoul-james-mindlab</link>
      <description><![CDATA[A Q&A with Larry Raoul James, CEO and President of MindLab, on why the opioid crisis was a drug design problem, and what it takes to build a next-generation pain therapeutic in a challenging category.]]></description>
      <pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6FTgWAiy4VhWaVTnLD7Ga9/43108bebc901b8ec4bd07a54bfdd174e/Cure_MSL_hero_article_LarryJames.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-oriana-zinani-phd</guid>
      <title><![CDATA[Cure Member Spotlight: Oriana Zinani, PhD]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-oriana-zinani-phd</link>
      <description><![CDATA[A Q&A with Oriana Zinani, PhD, Co-Founder and CEO of Applied PharmacoDynamics, on the science behind APD’s lead program for cocaine use disorder and what it takes to advance a first-in-class therapy in an area with enormous unmet need.
]]></description>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/ms3FWN4EGdQJ6aMKOzTo2/f7e04c7f01ab39318c9cc20bfb92b225/Cure_MSL_hero_article_Oriana_Zinani.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-matt-lewis</guid>
      <title><![CDATA[Cure Member Spotlight: Matt Lewis]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-matt-lewis</link>
      <description><![CDATA[A Q&A with Matt Lewis, CEO of Transformental, on why most AI transformations fail for human reasons, how healthcare organizations build “brain capital,” and what it takes to introduce AI responsibly in high-stakes environments.]]></description>
      <pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5nFnKlPMd5bVp1ivy0NpEM/a4b324b41a7afdaafc8441150c6cf890/Cure_MSL_hero_article_Matt_Lewis.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-karolyn-chamberlin</guid>
      <title><![CDATA[Cure Member Spotlight: Karolyn Chamberlin]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-karolyn-chamberlin</link>
      <description><![CDATA[A Q&A with Karolyn Chamberlin, COO of Rarecells, on the science behind ISET, why whole circulating tumor cells matter for early cancer detection, and the challenge of translating decades of academic research into clinical impact.]]></description>
      <pubDate>Fri, 30 Jan 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/UCn561idqZHgOpM6dXnO3/7e927c875e65ec9a0fd4f3a827a8c57c/Cure_MSL_hero_article_karolyn_chamberlin_rarecells.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-gilead-kedem-md</guid>
      <title><![CDATA[Cure Member Spotlight: Gilead Kedem, MD]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-gilead-kedem-md</link>
      <description><![CDATA[A Q&A with PolyCypher Health CEO Gilead Kedem, MD, on predicting chronic disease risk, rethinking polygenic scoring, and building preventive genomics for real-world care.]]></description>
      <pubDate>Fri, 09 Jan 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1HowXNjLFuugLrGa9FCwmc/d37f0ffb06c60ebf4722863fb222751e/Cure_MSL_hero_article_gilead_kedem_polycypher.png" medium="image" />
      <category>Article</category>
    </item>
  </channel>
</rss>